SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

TABLE OF CONTENTS

 

Page

 

Article I DEFINITIONS
Section 1.1   Certain Defined Terms 6
Section 1.2   Table of Definitions 22
Article II PURCHASE AND SALE
Section 2.1   Purchase and Sale of Assets 27
Section 2.2   Excluded Assets 29
Section 2.3   Assumed Liabilities 31
Section 2.4   Excluded Liabilities 31
Section 2.5   Consents to Certain Assignments 33
Section 2.6   Contract Designation 34
Section 2.7   Consideration 36
Section 2.8   Determination of the Purchase Price 36
Section 2.9   Closing 37
Section 2.10   Purchase Price Allocation 39
Section 2.11   Designated Buyer(s) 39
Section 2.12   Withholding 40
Article III REPRESENTATIONS AND WARRANTIES OF THE SELLERs
Section 3.1   Organization 41
Section 3.2   Authority 41
Section 3.3   No Conflict; Required Filings and Consents 42
Section 3.4   Transferred Assets 42
Section 3.5   SEC Documents; Financial Statements; No Undisclosed Liabilities 43
Section 3.6   Absence of Certain Changes or Events 44
Section 3.7   Compliance with Law; Permits 45
Section 3.8   Litigation 45
Section 3.9   Employee Plans 45
Section 3.10   Labor and Employment Matters 46
Section 3.11   Real Property 48
Section 3.12   Intellectual Property 49
Section 3.13   Taxes 50
Section 3.14   Regulatory Matters 50
Section 3.15   Privacy and Data Security 52
Section 3.16   Environmental Matters 53
Section 3.17   Material Contracts 54
Section 3.18   Accounts Receivable; Inventory 56
Section 3.19   Customers and Suppliers 56